Trinity Biotech plc TRIB
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$7.51$7.96
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | ||
|---|---|---|---|---|---|
| Net Income | -- | -- | -32.34% | 28.89% | |
| Total Depreciation and Amortization | -- | -- | 5.12% | -2.16% | |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | |
| Total Other Non-Cash Items | -- | -- | 51.27% | -42.68% | |
| Change in Net Operating Assets | -- | -- | 212.39% | 98.25% | |
| Cash from Operations | -- | -- | 63.71% | 26.76% | |
| Capital Expenditure | -- | -- | 49.56% | 51.56% | |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | |
| Divestitures | -- | -- | -- | -100.00% | |
| Other Investing Activities | -- | -- | -686.99% | -614.16% | |
| Cash from Investing | -- | -- | -192.78% | -186.18% | |
| Total Debt Issued | -- | -- | 503.50% | 463.39% | |
| Total Debt Repaid | -- | -- | 79.77% | 80.73% | |
| Issuance of Common Stock | -- | -- | -- | 1,772.89% | |
| Repurchase of Common Stock | -- | -- | -- | -- | |
| Issuance of Preferred Stock | -- | -- | -- | -- | |
| Repurchase of Preferred Stock | -- | -- | -- | -- | |
| Total Dividends Paid | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | 24.80% | 11.49% | |
| Cash from Financing | -- | -- | 279.56% | 260.97% | |
| Foreign Exchange rate Adjustments | -- | -- | -295.45% | -263.27% | |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | |
| Net Change in Cash | -- | -- | 151.13% | -244.51% | |